MicroRNAs in central nervous system diseases: A prospective role in regulating blood-brain barrier integrity

被引:61
|
作者
Ma, Feifei [1 ]
Zhang, Xuejing [1 ]
Yin, Ke-Jie [1 ,2 ]
机构
[1] Univ Pittsburgh, Sch Med, Dept Neurol, Pittsburgh Inst Brain Disorders & Recovery, 200 Lothrop St,BST 5514, Pittsburgh, PA 15213 USA
[2] Vet Affairs Pittsburgh Healthcare Syst, Geriatr Res Educ & Clin Ctr, Pittsburgh, PA 15261 USA
基金
美国国家卫生研究院;
关键词
MicroRNAs; Central nervous system diseases; Blood-brain barrier; Vascular integrity; TUMOR BARRIER; CEREBRAL-ISCHEMIA; TIGHT JUNCTIONS; INTRACEREBRAL HEMORRHAGE; EXPRESSION CHANGES; STROKE OUTCOMES; IN-VITRO; PERMEABILITY; DYSFUNCTION; DISRUPTION;
D O I
10.1016/j.expneurol.2019.113094
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Given the essential role of the blood-brain barrier (BBB) in the central nervous system (CNS), cumulative investigations have been performed to elucidate how modulation of BBB structural and functional integrity affects the pathogenesis of CNS diseases such as stroke, traumatic brain injuries, dementia, and cerebral infection. Recent studies have demonstrated that microRNAs (miRNAs) contribute to the maintenance of the BBB and thereby mediate CNS homeostasis. This review summarizes emerging studies that demonstrate cerebral miRNAs regulate BBB function in CNS disorders, emphasizing the direct role of miRNAs in BBB molecular composition. Evidence presented in this review will encourage a deeper understanding of the mechanisms by which miRNAs regulate BBB function, and facilitate the development of new miRNAs-based therapies in patients with CNS diseases.
引用
收藏
页数:11
相关论文
共 50 条
  • [41] DIFFERENCES IN EFFECTIVITY OF THE BLOOD-BRAIN BARRIER IN DIFFERENT PARTS OF CENTRAL NERVOUS SYSTEM
    Brattgard, Sven-Olof
    Lindqvist, Torsten
    ACTA PSYCHIATRICA ET NEUROLOGICA SCANDINAVICA, 1955, 30 (03): : 423 - 436
  • [42] ABSENCE OF BLOOD-BRAIN BARRIER FROM CERTAIN AREAS OF CENTRAL NERVOUS SYSTEM
    WILSON, CW
    BRODIE, BB
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1961, 133 (03): : 332 - &
  • [43] Exposure of quantum dots in the nervous system: Central nervous system risks and the blood-brain barrier interface
    Guan, Shujing
    Tang, Meng
    JOURNAL OF APPLIED TOXICOLOGY, 2024, 44 (07) : 936 - 952
  • [44] Targeting the central nervous system in lysosomal storage diseases: Strategies to deliver therapeutics across the blood-brain barrier
    Critchley, Bethan J.
    Gaspar, H. Bobby
    Benedetti, Sara
    MOLECULAR THERAPY, 2023, 31 (03) : 657 - 675
  • [45] Drug Development for Central Nervous System Diseases Using In vitro Blood-brain Barrier Models and Drug Repositioning
    Morofuji, Yoichi
    Nakagawa, Shinsuke
    CURRENT PHARMACEUTICAL DESIGN, 2020, 26 (13) : 1466 - 1485
  • [46] The role of exosomal microRNAs in central nervous system diseases
    Yu, Yifei
    Hou, Kun
    Ji, Tong
    Wang, Xishu
    Liu, Yining
    Zheng, Yangyang
    Xu, Jinying
    Hou, Yi
    Chi, Guangfan
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2021, 476 (05) : 2111 - 2124
  • [47] The role of exosomal microRNAs in central nervous system diseases
    Yifei Yu
    Kun Hou
    Tong Ji
    Xishu Wang
    Yining Liu
    Yangyang Zheng
    Jinying Xu
    Yi Hou
    Guangfan Chi
    Molecular and Cellular Biochemistry, 2021, 476 : 2111 - 2124
  • [48] Central nervous system complications of diabetes mellitus - A perspective from the blood-brain barrier
    Mooradian, AD
    BRAIN RESEARCH REVIEWS, 1997, 23 (03) : 210 - 218
  • [49] Drug metabolism and pharmacokinetics, the blood-brain barrier, and central nervous system drug discovery
    Alavijeh M.S.
    Chishty M.
    Qaiser M.Z.
    Palmer A.M.
    NeuroRX, 2005, 2 (4): : 554 - 571
  • [50] Maculopathy as a complication of blood-brain barrier disruption in patients with central nervous system lymphoma
    Galor, Anat
    Ference, Sandra J.
    Singh, Arun D.
    Lee, Michael S.
    Stevens, Glen H. J.
    Perez, Victor L.
    Peereboom, David M.
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2007, 144 (01) : 45 - 49